Abstract
The ability of wastewater-based surveillance (WBS) to infer viral loads in communities was showcased during the COVID-19 pandemic. Whether WBS could be used to track other microorganisms is less studies. We tested for Salmonella enterica, a common foodborne pathogen, in community wastewater and investigated whether such isolates could be linked to past or ongoing outbreaks. During June 2022, composite wastewater samples were collected from treatment facilities in two communities in central Pennsylvania. A total of 42 confirmed S. enterica isolates were whole genome sequenced, revealing 7 different serovariants. Four isolates identified as S. enterica ser. Senftenberg were in a cluster, separated by 0-4 SNPs from clinical isolates uploaded to the web-based National Centers for Biotechnology Information Pathogen Detection platform. Most isolates in the cluster were previously associated with a 2022 multistate foodborne outbreak that was caused by contaminated peanut butter. Our targeted study suggests that wastewater-based surveillance for Salmonella would complement public health efforts by providing information about the extent of an outbreak and help focus public health resources and guidance to areas most impacted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the US Food and Drug Administration (Grant No. 1U19FD007114-01), and the USDA National Institute of Food and Agriculture and Hatch Appropriations PEN4826, PEN04853, and Multistate project 4666.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All sequencing data was deposited in the NCBI Sequence Read Archive (SRA) (https://www.ncbi.nlm.nih.gov/sra) under BioProject PRJNA357723.
